|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07K 16/2818 | (2013.01) |
| C40B 30/04 | (2006.01) | ||
| A61K 39/00 | (2006.01) | ||
| A61K2039/505 | (2013.01) | ||
| A61K 39/395 | (2006.01) | ||
| C07K2317/24 | (2013.01) | ||
| C07K2317/76 | (2013.01) | ||
| C12Q 1/68 | (2013.01) | ||
| C12Q2600/106 | (2013.01) | ||
| C12Q2600/158 | (2013.01) | ||
| G16B 20/00 | (2019.02) | ||
| G16B 30/00 | (2019.02) | ||
| G16B 40/00 | (2019.02) | ||
| C12Q 1/6886 | (2013.01) | ||
| A61P 35/00 | (2018.01) | ||
| A61P 43/00 | (2018.01) | ||
| G16B 40/30 | (2019.02) | ||
| G16B 20/20 | (2019.02) |
| (11) | Number of the document | 3230498 |
| (13) | Kind of document | T |
| (96) | European patent application number | 15868101.5 |
| Date of filing the European patent application | 2015-12-08 | |
| (97) | Date of publication of the European application | 2017-10-18 |
| (45) | Date of publication and mention of the grant of the patent | 2023-01-18 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2015/064445 |
| Date | 2015-12-08 |
| (87) | Number | WO 2016/094377 |
| Date | 2016-06-16 |
| (30) | Number | Date | Country code |
| 201462089538 P | 2014-12-09 | US | |
| 201562160284 P | 2015-05-12 | US |
| (72) |
AYERS, Mark, D. , US
LOBODA, Andrey , US
LUNCEFORD, Jared, K. , US
MCCLANAHAN, Terrill, K. , US
MURPHY, Erin, E. , US
NEBOZHYN, Michael , US
|
| (73) |
Merck Sharp & Dohme LLC ,
126 East Lincoln Avenue, Rahway, New Jersey 07065,
US
|
| (54) | SYSTEM AND METHODS FOR DERIVING GENE SIGNATURE BIOMARKERS OF RESPONSE TO PD-1 ANTAGONISTS |
| SYSTEM AND METHODS FOR DERIVING GENE SIGNATURE BIOMARKERS OF RESPONSE TO PD-1 ANTAGONISTS |